These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1887135)

  • 1. The use of inhaled formoterol in asthma.
    Senn S; Richardson WN; Shaw M
    Respir Med; 1991 Mar; 85(2):169-70. PubMed ID: 1887135
    [No Abstract]   [Full Text] [Related]  

  • 2. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.
    Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):622-5. PubMed ID: 1892303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting beta(2)-agonists in childhood asthma: Don't change a winning team (yet).
    Verberne AA; de Jongste JC
    Pediatr Pulmonol; 2000 Mar; 29(3):169-71. PubMed ID: 10686035
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of the duration of the bronchodilator effect of 12 micrograms and 24 micrograms of inhaled formoterol and 200 micrograms inhaled salbutamol in asthma.
    Sykes AP; Ayres JG
    Respir Med; 1990 Mar; 84(2):135-8. PubMed ID: 2371435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalence of a single saline nebulised dose of formoterol powder vs three doses of nebulised Albuterol every twenty minutes in acute asthma in children: a suitable cost effective approach for developing nations.
    Rodriguez E; Vera V; Perez-Puigbo A; Capriles-Hulett A; Ferro S; Manrique J; Abate J
    Allergol Immunopathol (Madr); 2008; 36(4):196-200. PubMed ID: 18928685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are there any detrimental effects of the use of inhaled long-acting beta 2-agonists in the treatment of asthma?
    Devoy MA; Fuller RW; Palmer JB
    Chest; 1995 Apr; 107(4):1116-24. PubMed ID: 7705125
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventive effects of inhaled formoterol and salbutamol on histamine-induced bronchoconstriction--a placebo-controlled study.
    Sovijärvi AR; Reinikainen K; Freudenthal Y; Andersson P; Riska H
    Respiration; 1992; 59(5):279-82. PubMed ID: 1488561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours.
    Maesen FP; Smeets JJ; Gubbelmans HL; Zweers PG
    Chest; 1990 Mar; 97(3):590-4. PubMed ID: 1968371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of inhaled formoterol and budesonide in reducing asthma exacerbations.
    Pauwels R
    Allergy; 1998; 53(42 Suppl):20-3. PubMed ID: 9615842
    [No Abstract]   [Full Text] [Related]  

  • 11. Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration.
    Löfdahl CG; Svedmyr N
    Allergy; 1989 May; 44(4):264-71. PubMed ID: 2544117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formoterol fumarate inhalation powder vs albuterol nebulizer for the treatment of asthma in the acute care setting.
    Lee-Wong M; Chou V; Ogawa Y
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):146-52. PubMed ID: 18320916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.
    Wallin A; Melander B; Rosenhall L; Sandström T; Wåhlander L
    Thorax; 1990 Apr; 45(4):259-61. PubMed ID: 1972599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics.
    Rosenborg J; Bengtsson T; Larsson P; Blomgren A; Persson G; Lötvall J
    Eur J Clin Pharmacol; 2000 Aug; 56(5):363-70. PubMed ID: 11009043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma exacerbations and formoterol.
    Rissmiller RW; Larj MJ; Peters SP; Bleecker ER
    Chest; 2004 Apr; 125(4):1590-1. PubMed ID: 15078782
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration.
    Lipworth BJ; Aziz I
    Chest; 2000 Jan; 117(1):156-62. PubMed ID: 10631214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new fixed dose combination of fluticasone and formoterol in a pressurised metered-dose inhaler for the treatment of asthma].
    Devillier P; Salvator H; Grassin-Delyle S; Naline E; Advenier C; Roche N
    Rev Mal Respir; 2014 Oct; 31(8):700-13. PubMed ID: 25391505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
    Lipworth BJ; Aziz I
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formoterol, a new long-acting beta 2 agonist, inhaled twice daily, in stable asthmatic subjects.
    Midgren B; Melander B; Persson G
    Chest; 1992 Apr; 101(4):1019-22. PubMed ID: 1348219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.